🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John A. Zebala

Syntrix Biosystems (United States)

ORCID: 0000-0002-3581-6750
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity”.

Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000326
N/A
0DataRank · unranked
97 citations

Jeffrey Riskin, Heidi Hempel, Kristen Fousek, Hanne Lind, Duane H. Hamilton +7 more

Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0369
N/A
0DataRank · unranked
103 citations

Shuai Li, Alireza Khodadadi‐Jamayran, Jayu Jen, Han Han, Kayla Guidry +13 more

Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast

Nature Communications(2021)10.1038/s41467-021-25240-z
N/A
0DataRank · unranked
21 citations

Amanda L. Rinkenbaugh, Mingchu Xu, Xinhui Zhou, Xiaomei Zhang, Sabrina L. Jeter-Jones +7 more

Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.21.436338
N/A
0DataRank · unranked
15 citations

Shuai Li, Alireza Khodadadi‐Jamayran, Jayu Jen, Han Han, Kayla Guidry +11 more

Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast

Research Square(2021)10.21203/rs.3.rs-179498/v1
N/A
0DataRank · unranked
0 citations

Amanda L. Rinkenbaugh, Mingchu Xu, Xinhui Zhou, Xiaomei Zhang, Sabrina L. Jeter-Jones +7 more

A phase I study to evaluate the safety and tolerability of SX-682 in combination with PD-1 inhibitor as maintenance therapy for unresectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps631
N/A
0DataRank · unranked
10 citations

Nicholas A. Ullman, Brian A. Belt, Luis I. Ruffolo, Paul R. Burchard, Aram F. Hezel +7 more

Tumor-induced endothelial RhoA activation mediates tumor cell transendothelial migration and metastasis

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.22.614304
N/A
0DataRank · unranked
2 citations

Fatema Tuz Zahra, Μαργαρίτα Λάμπρου, Racheal G. Akwii, Jee Hyun Park, Manuel Osorio +18 more